CIK 0001828673 · <br>Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825024477
- Phone
- 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- 4 Grant or award Director acquired 35,714 shares (grant or award)
- 4 Grant or award Director acquired 35,715 shares (grant or award)
- 4 Grant or award Director acquired 142,858 shares (grant or award)
- 4 Grant or award SVP of Business Development acquired 71,429 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 760,714 shares (grant or award)
- 4 Option exercise See Remarks acquired 14,000 shares (option exercise)
- 4 Option exercise SVP of Business Development acquired 7,501 shares (option exercise)
- 4 Option exercise See Remarks acquired 15,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 47,249 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 1,800 shares at $2.08 ($3,741)
- 4 Open-market buy Director bought 1,587 shares at an average $2.05 ($3,256)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $2.10 ($10,490)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $2.07 ($20,715)
- 4 Open-market buy Director bought 600 shares at an average $2.05 ($1,230)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $1.99 ($19,853)
- 4 Open-market buy Director bought 463 shares at an average $1.78 ($823)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.95 ($9,749)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 6 · 109 filings